What happens when your food-allergic teenager is several hours away from home, and his team’s bus pulls up to an unfamiliar restaurant? For Megan Lavin’s son, it all went smoothly. But there’s an ...
Hoping second time will be the charm, Aquestive resubmits the needle-free Anaphylm epinephrine film to the FDA for review.
Good results on Teva's lab-made antibody that blocks gluten damage raise hopes that a treatment for celiac disease may ...
The Girl Scouts are launching a new allergy-friendly, gluten-free cookie. Allergy moms and daughters are jumping for joy.
Aquestive Therapeutics has completed the additional research that the Food and Drug Administration required to consider approval for Anaphylm. The company says it has positive results to show the FDA ...
Research into using fecal transplantation of gut bacteria from healthy donors to treat peanut allergy is moving into its next phase. Recruitment is nearly complete for the first part of a Phase 2 ...
Inclusion and hospitality are key ingredients in Chef Bradley Shannon’s recipe for elevating the dining experience for students with food allergies and special diet needs. The director of culinary ...
The Federal Aviation Administration has released its long-awaited proposed rule to update the emergency medical kits (EMKs) on U.S. commercial flights. Food allergy advocates had hoped this would be a ...
A tablet placed under the tongue increased peanut tolerance in about half of allergic children and adults after six months of daily treatment. Known as sublingual immunotherapy, or SLIT, the rapidly ...
Two years ago, I wrote in Allergic Living about what appeared to be a turning point for passengers at risk of anaphylaxis. After years of advocacy by physicians, patients and allergy organizations, ...
Xolair, the first medication shown to help protect from allergic reactions to multiple food allergens, is about to have company. A wave of Xolair biosimilars is headed for the U.S. market. The ...
About a decade ago, it took a lot of advocacy to achieve state laws allowing stock epinephrine at school in nearly every U.S. state. And now, “stock epi” advocacy is underway again – this time ...